LOW INCIDENCE OF POSTTRANSPLANT MYELODYSPLASIA ACUTE-LEUKEMIA (MDS AML) IN NHL PATIENTS AUTOTRANSPLANTED AFTER AFTER CYCLOPHOSPHAMIDE, CARMUSTINE AND ETOPOSIDE (CBV)/
C. Wheeler et al., LOW INCIDENCE OF POSTTRANSPLANT MYELODYSPLASIA ACUTE-LEUKEMIA (MDS AML) IN NHL PATIENTS AUTOTRANSPLANTED AFTER AFTER CYCLOPHOSPHAMIDE, CARMUSTINE AND ETOPOSIDE (CBV)/, Blood, 90(10), 1997, pp. 4480-4480